This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Methotrexate rheumatology guidelines

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Methotrexate is an antifolate drug used in chemotherapy. Its action is to bind dihydrofolate reductase.

It is indicated for the treatment of various malignancies at high dose and for the treatment of psoriasis and rheumatoid arthritis as a titrated weekly dose (1).

The summary of product characteristics should be consulted before prescribing this drug.

Reference:

  • (1) Current Problems in Pharmacovigilance (2000), 26, 10.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.